Sanofi connects with diabetics using social media

Sanofi ($SNY) wants to know more about diabetes patients. So, the French drugmaker is using a variety of social media channels as windows into those patients' lives. It's part of the company's multipronged strategy for winning over the fast-growing diabetes market. Report